Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jul;80(10):1588–1594. doi: 10.1038/sj.bjc.6690567

Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy

A S Allal 1, M A G Sprangers 3, F Laurencet 1, M A Reymond 2, J M Kurtz 1
PMCID: PMC2363100  PMID: 10408404

Abstract

This study was conducted to assess long-term Quality of Life (QOL) in patients treated by radiotherapy with or without chemotherapy for anal carcinomas. Patients with a maximum age of 80 years, and who were alive at least 3 years following completion of treatment with a functioning anal sphincter and without active disease, were selected for this study. Of 52 such patients identified, 41 (79%) were evaluable. There were 35 females and six males with a median age of 71 years (55–80). The median follow-up interval was 116 months (range 37–218). QOL was assessed using two self-rating questionnaires developed by the European Organization for Research and Treatment of Cancer: one for cancer-specific QOL (EORTC QLQ-C30) and one for site-specific QOL (EORTC QLQ-CR38). For the function scales a higher score represents a higher level of functioning (100 being the best score), whereas for the symptom scales a higher score indicates a higher level of symptomatology/problems (0 being the best score). For the QLQ-C30, the functional scale scores ranged from 71 (global quality of life) to 85 (role function) and the symptom scale scores from 6 (nausea-vomiting) to 28 (diarrhoea). For the QLQ-CR38 module the functional scale scores ranged from 13 (sexual functioning) to 74 (body image) and for the symptom scale scores from 5 (weight loss) to 66 (sexual dysfunction in males). None of the functional and symptom scale scores seemed to be better in patients with longer follow-up. In patients treated with sphincter conservation for anal carcinomas, long-term QOL as measured by the EORTC QLQ-C30 and QLQ-CR38 appears to be acceptable, with the exception of diarrhoea and perhaps sexual function. Moreover, the subset of patients who presented with severe complications and/or anal dysfunction showed poorer scores in most scales. © 1999 Cancer Research Campaign

Keywords: anal carcinoma, quality of life, radiotherapy, chemotherapy

Full Text

The Full Text of this article is available as a PDF (88.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson N. K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N. J., Filiberti A., Flechtner H., Fleishman S. B., de Haes J. C. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365–376. doi: 10.1093/jnci/85.5.365. [DOI] [PubMed] [Google Scholar]
  2. Allal A. S., Mermillod B., Roth A. D., Marti M. C., Kurtz J. M. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1099–1105. doi: 10.1016/s0360-3016(97)00390-8. [DOI] [PubMed] [Google Scholar]
  3. Allal A., Kurtz J. M., Pipard G., Marti M. C., Miralbell R., Popowski Y., Egeli R. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):59–66. doi: 10.1016/0360-3016(93)90421-q. [DOI] [PubMed] [Google Scholar]
  4. Andersen B. L., Anderson B., deProsse C. Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes. J Consult Clin Psychol. 1989 Dec;57(6):683–691. doi: 10.1037//0022-006x.57.6.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anderson B., Lutgendorf S. Quality of life in gynecologic cancer survivors. CA Cancer J Clin. 1997 Jul-Aug;47(4):218–225. doi: 10.3322/canjclin.47.4.218. [DOI] [PubMed] [Google Scholar]
  6. Crook J., Esche B., Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology. 1996 Mar;47(3):387–394. doi: 10.1016/S0090-4295(99)80458-0. [DOI] [PubMed] [Google Scholar]
  7. Gelber R. D., Goldhirsch A., Cole B. F., Wieand H. S., Schroeder G., Krook J. E. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J Natl Cancer Inst. 1996 Aug 7;88(15):1039–1045. doi: 10.1093/jnci/88.15.1039. [DOI] [PubMed] [Google Scholar]
  8. Kapp K. S., Stuecklschweiger G. F., Kapp D. S., Poschauko J., Pickel H., Hackl A. Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol. 1997 Feb;42(2):143–153. doi: 10.1016/s0167-8140(96)01881-6. [DOI] [PubMed] [Google Scholar]
  9. Klee M., Groenvold M., Machin D. Quality of life of Danish women: population-based norms of the EORTC QLQ-C30. Qual Life Res. 1997 Jan;6(1):27–34. doi: 10.1023/a:1026461310761. [DOI] [PubMed] [Google Scholar]
  10. Minsky B. D., Cohen A. M., Enker W. E., Sigurdson E. Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys. 1992;23(2):387–392. doi: 10.1016/0360-3016(92)90757-9. [DOI] [PubMed] [Google Scholar]
  11. Nigro N. D. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum. 1984 Dec;27(12):763–766. doi: 10.1007/BF02553933. [DOI] [PubMed] [Google Scholar]
  12. Papillon J., Montbarbon J. F., Gerard J. P., Chassard J. L., Ardiet J. M. Interstitial curietherapy in the conservative treatment of anal and rectal cancers. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1161–1169. doi: 10.1016/0360-3016(89)90521-x. [DOI] [PubMed] [Google Scholar]
  13. Papillon J. Radiation therapy in the management of epidermoid carcinoma of the anal region. Dis Colon Rectum. 1974 Mar-Apr;17(2):181–187. doi: 10.1007/BF02588101. [DOI] [PubMed] [Google Scholar]
  14. Sedgwick D. M., Howard G. C., Ferguson A. Pathogenesis of acute radiation injury to the rectum. A prospective study in patients. Int J Colorectal Dis. 1994 Apr;9(1):23–30. doi: 10.1007/BF00304295. [DOI] [PubMed] [Google Scholar]
  15. Sprangers M. A., Taal B. G., Aaronson N. K., te Velde A. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum. 1995 Apr;38(4):361–369. doi: 10.1007/BF02054222. [DOI] [PubMed] [Google Scholar]
  16. Touboul E., Schlienger M., Buffat L., Lefkopoulos D., Pène F., Parc R., Tiret E., Gallot D., Malafosse M., Laugier A. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer. 1994 Mar 15;73(6):1569–1579. doi: 10.1002/1097-0142(19940315)73:6<1569::aid-cncr2820730607>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  17. Williams N. S., Johnston D. The quality of life after rectal excision for low rectal cancer. Br J Surg. 1983 Aug;70(8):460–462. doi: 10.1002/bjs.1800700805. [DOI] [PubMed] [Google Scholar]
  18. Yeoh E., Horowitz M., Russo A., Muecke T., Robb T., Maddox A., Chatterton B. Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study. Am J Med. 1993 Oct;95(4):397–406. doi: 10.1016/0002-9343(93)90309-d. [DOI] [PubMed] [Google Scholar]
  19. Yeoh E., Sun W. M., Russo A., Ibanez L., Horowitz M. A retrospective study of the effects of pelvic irradiation for gynecological cancer on anorectal function. Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):1003–1010. doi: 10.1016/0360-3016(96)00147-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES